ISO 17043 (I) | ||
Homogeneity and stability testing | Wim Coucke | |
The perspective of the accreditation body | Martin Stearn | |
The ISO17043 from the perspective of Laboratory Medicine: Do we need a revision? (results of a questionnaire + discussion) | Piet Meijer | |
Abstract presentations (I) | ||
Development of Belgian guidelines for the minimal frequency of participation to method and disease-based genetic proficiency testing in the context of hereditary rare diseases | Joséphine Lantoine | Weqas INR Programme – An Example of Post Market Vigilance | Samantha Jones |
Adam Uldall Lecture | ||
EQA– future challenges and opportunities | Annette Thomas | |
Molecular Genetics | ||
The effect of global migration on the European population genotype | Dorret Boomsma | |
EQA in genetic testing | -- | Fiona Morgan |
EQALM collaborations | ||
Harmonisation and traceability: a global effort (introduction + discussion) | Sverre Sandberg and Eline van der Hagen | |
Quality of interpretative comments | -- | Eva Ajzner |
Introduction on the Task and Finishing group on Immunology | -- | Dina Patel |
ISO 17043 (II) | ||
Commutability of EQA samples, how to assess | -- | Vincent Delatour |
Abstract presentations (II) | ||
Contribution from local organizer, SNEQAS | Saša Bratož | |
ProMeQuaLab - Project of Laboratory Quality Improvement for Portuguese Speaking Countries. Tasks during 2015-2019 | Ana Faria |